胸主动脉腔内修复术前胸椎骨骼肌减少症评估的推导与验证
本研究基于147例接受胸主动脉腔内修复术患者的术前CT,以腰大肌骨骼肌减少症为参照,建立并验证T12水平胸椎骨骼肌减少症的标准化测量方法。ROC分析得出女性T12阈值106.00 cm2/m2、男性110.00 cm2/m2,准确性高,观察者间与观察者内信度优良,可作为无腹部CT时评估骨骼肌减少症的替代方法。
要点
- T12水平胸肌面积可可靠评估骨骼肌减少症,女性阈值106.00 cm2/m2、男性110.00 cm2/m2。
- T12测量与L3腰大肌骨骼肌减少症一致性良好,ROC曲线下面积男性0.91、女性0.90。
- 观察者间与观察者内定量信度ICC均>0.95,定性信度Cohen κ>0.85。
核心结论
- 胸椎骨骼肌减少症可通过CT测量T12水平肌肉面积简便且可靠地重现,可作为无腹部CT患者客观定义骨骼肌减少症的替代方法。
研究设计与样本
- 前瞻性收集接受胸主动脉腔内修复术(因胸主动脉夹层、动脉瘤或损伤)并使用适形胸主动脉支架患者的数据进行回顾性分析。
- 纳入具有术前腹部和胸部CT影像的患者,共147例,包括夹层34例、创伤80例、动脉瘤33例。
- 在T12水平采用新建立的标准化计算机辅助方案测量胸肌面积,在L3水平采用标准方法测量腰大肌骨骼肌减少症。
- 通过ROC曲线分析确定性别特异性T12最佳诊断测量值,部分扫描由两名训练有素观察者重复判读,采用组内相关系数检验观察者内和观察者间信度。
- 采用Cohen κ(范围0-1)检验T12与L3骨骼肌减少症之间的一致性。
主要发现
- ROC曲线分析得出T12水平骨骼肌减少症截断值:女性106.00 cm2/m2,男性110.00 cm2/m2。
- 基于ROC曲线分析,T12测量的总体准确性高,男性曲线下面积0.91,女性0.90。
- 定量观察者间和观察者内信度组内相关系数均>0.95。
- 定性观察者间信度Cohen κ均>0.85。
- 在T12和L3水平计算骨骼肌减少症的定性观察者内信度对两名阅读者均为中等(0.361和0.288)。
关键数值与推荐
- T12水平骨骼肌减少症截断值:女性106.00 cm2/m2,男性110.00 cm2/m2。
- T12测量诊断准确性:男性ROC曲线下面积0.91,女性0.90。
- 定量信度:观察者间和观察者内ICC均>0.95;定性观察者间信度Cohen κ>0.85。
- 定性观察者内信度:T12和L3水平计算骨骼肌减少症对两名阅读者分别为0.361和0.288。
临床怎么用
- 对于无腹部CT影像的胸主动脉疾病患者,可采用T12水平CT肌肉面积测量客观评估骨骼肌减少症。
- 根据性别采用相应T12截断值(女性106.00 cm2/m2、男性110.00 cm2/m2)判断骨骼肌减少症。
- 该测量方法具有高重复性和观察者间信度,适合临床标准化应用。
局限性
- 定性观察者内信度在T12和L3水平均为中等(0.361和0.288),提示定性判读一致性有限。
- 胸椎与腹部骨骼肌减少症对术后结局的预测价值尚未评估,需未来研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Sarcopenia, as assessed by computed tomography (CT)-based measurements of muscle mass, is an objective and patient-specific indicator of frailty, which is an important predictor of operative morbidity and mortality. Studies to date have primarily focused on psoas-defined sarcopenia, which may not be valid among patients with thoracic aortic disease. Using psoas sarcopenia as the reference for sarcopenia, the purpose of this study was to create and to validate a new thoracic-level method of measuring sarcopenia as a novel method to assess frailty among patients undergoing thoracic endovascular aortic repair. METHODS: Prospectively collected data of patients undergoing thoracic endovascular aortic repair for thoracic aortic dissection, aneurysm, or injury using a conformable thoracic graft were reviewed. Patients with preoperative abdominal and thoracic CT imaging were included. Thoracic muscle mass was measured on axial images at the T12 level using our newly established standardized computer-assisted protocol. Psoas sarcopenia was measured at the L3 level using standard methods. Optimal sex-specific diagnostic T12 measurements were determined by receiver operating characteristic (ROC) curve analysis. A subset of scans were reviewed in duplicate by two trained observers and intraobserver and interobserver reliability tested by intraclass correlation coefficient. Agreement between T12 and L3 sarcopenia was tested by Cohen κ (scale, 0-1). RESULTS: There were 147 patients included for analysis, including 34 dissection, 80 trauma, and 33 aneurysm patients. ROC curve analysis yielded sarcopenic cutoff values of 106.00 cm2/m2 for women and 110.00 cm2/m2 for men at the T12 level. Based on ROC curve analysis, overall accuracy of T12 measurements was high (area under ROC curve, 0.91 for men and 0.90 for women). Quantitative interobserver and intraobserver reliability yielded excellent intraclass correlation coefficient values (>0.95). Qualitative interobserver reliability yielded nearly perfect Cohen κ values (>0.85). Qualitative intraobserver reliability of calculating sarcopenia at both the T12 and L3 levels was fair for both readers (0.361 and 0.288). There was additionally a general correlation between changes in muscle area at L3 with changes at T12 during 48 months. CONCLUSIONS: Thoracic sarcopenia can be readily and reliably reproduced from CT-derived measurement of T12-level muscle area. This approach may be used as an alternative method to objectively define sarcopenia in patients without abdominal CT imaging. Future studies to assess the predictability of thoracic vs abdominal sarcopenia on postoperative outcomes will enhance the utility of these tools.
引用
- Panthofer AM, Olson SL, Harris DG, et al. Derivation and validation of thoracic sarcopenia assessment in patients undergoing thoracic endovascular aortic repair. J Vasc Surg. 2018. PMID: 30598352. doi:10.1016/j.jvs.2018.08.180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。